Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,599 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Role of Serum Carcinoma Embryonic Antigen (CEA) Level in Localized Pancreatic Adenocarcinoma: CEA Level Before Operation is a Significant Prognostic Indicator in Patients With Locally Advanced Pancreatic Cancer Treated With Neoadjuvant Therapy Followed by Surgical Resection: A Retrospective Analysis.
Kato H, Kishiwada M, Hayasaki A, Chipaila J, Maeda K, Noguchi D, Gyoten K, Fujii T, Iizawa Y, Tanemura A, Murata Y, Kuriyama N, Usui M, Sakurai H, Isaji S, Mizuno S. Kato H, et al. Among authors: sakurai h. Ann Surg. 2022 May 1;275(5):e698-e707. doi: 10.1097/SLA.0000000000004148. Epub 2020 Jul 24. Ann Surg. 2022. PMID: 32744820
Gemcitabine-based chemoradiotherapy followed by surgery for borderline resectable and locally unresectable pancreatic ductal adenocarcinoma: significance of the CA19-9 reduction rate and intratumoral human equilibrative nucleoside transporter 1 expression.
Kobayashi M, Mizuno S, Murata Y, Kishiwada M, Usui M, Sakurai H, Tabata M, Ii N, Yamakado K, Inoue H, Shiraishi T, Yamada T, Isaji S. Kobayashi M, et al. Among authors: sakurai h. Pancreas. 2014 Apr;43(3):350-60. doi: 10.1097/MPA.0000000000000059. Pancreas. 2014. PMID: 24622063 Free PMC article.
Predictive risk factors for early recurrence in patients with localized pancreatic ductal adenocarcinoma who underwent curative-intent resection after preoperative chemoradiotherapy.
Murata Y, Ogura T, Hayasaki A, Gyoten K, Ito T, Iizawa Y, Fujii T, Tanemura A, Kuriyama N, Kishiwada M, Sakurai H, Mizuno S. Murata Y, et al. Among authors: sakurai h. PLoS One. 2022 Apr 4;17(4):e0264573. doi: 10.1371/journal.pone.0264573. eCollection 2022. PLoS One. 2022. PMID: 35377885 Free PMC article.
A new surgical technique of pancreaticoduodenectomy with splenic artery resection for ductal adenocarcinoma of the pancreatic head and/or body invading splenic artery: impact of the balance between surgical radicality and QOL to avoid total pancreatectomy.
Desaki R, Mizuno S, Tanemura A, Kishiwada M, Murata Y, Azumi Y, Kuriyama N, Usui M, Sakurai H, Tabata M, Isaji S. Desaki R, et al. Among authors: sakurai h. Biomed Res Int. 2014;2014:219038. doi: 10.1155/2014/219038. Epub 2014 Jun 12. Biomed Res Int. 2014. PMID: 25013768 Free PMC article.
Comparative Study Between Gemcitabine-Based and Gemcitabine Plus S1-Based Preoperative Chemoradiotherapy for Localized Pancreatic Ductal Adenocarcinoma, With Special Attention to Initially Locally Advanced Unresectable Tumor.
Takeuchi T, Mizuno S, Murata Y, Hayasaki A, Kishiwada M, Fujii T, Iizawa Y, Kato H, Tanemura A, Kuriyama N, Azumi Y, Usui M, Sakurai H, Isaji S. Takeuchi T, et al. Among authors: sakurai h. Pancreas. 2019 Feb;48(2):281-291. doi: 10.1097/MPA.0000000000001227. Pancreas. 2019. PMID: 30629019
The clinical impact of portal venous patency ratio on prognosis of patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy with combined resection of portal vein following preoperative chemoradiotherapy.
Jaseanchiun W, Kato H, Hayasaki A, Fujii T, Iizawa Y, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Kishiwada M, Mizuno S, Usui M, Sakurai H, Isaji S. Jaseanchiun W, et al. Among authors: sakurai h. Pancreatology. 2019 Mar;19(2):307-315. doi: 10.1016/j.pan.2019.01.020. Epub 2019 Jan 25. Pancreatology. 2019. PMID: 30738764
High tumor budding is a strong predictor of poor prognosis in the resected perihilar cholangiocarcinoma patients regardless of neoadjuvant therapy, showing survival similar to those without resection.
Ito T, Kuriyama N, Kozuka Y, Komatsubara H, Ichikawa K, Noguchi D, Hayasaki A, Fujii T, Iizawa Y, Kato H, Tanemura A, Murata Y, Kishiwada M, Mizuno S, Usui M, Sakurai H, Isaji S. Ito T, et al. Among authors: sakurai h. BMC Cancer. 2020 Mar 12;20(1):209. doi: 10.1186/s12885-020-6695-9. BMC Cancer. 2020. PMID: 32164621 Free PMC article.
Neoadjuvant chemotherapy followed by curative-intent surgery for perihilar cholangiocarcinoma based on its anatomical resectability classification and lymph node status.
Kuriyama N, Usui M, Gyoten K, Hayasaki A, Fujii T, Iizawa Y, Kato H, Murata Y, Tanemura A, Kishiwada M, Sakurai H, Mizuno S, Isaji S. Kuriyama N, et al. Among authors: sakurai h. BMC Cancer. 2020 May 11;20(1):405. doi: 10.1186/s12885-020-06895-1. BMC Cancer. 2020. PMID: 32393197 Free PMC article.
Pancreas-visceral fat CT value ratio and serrated pancreatic contour are strong predictors of postoperative pancreatic fistula after pancreaticojejunostomy.
Kusafuka T, Kato H, Iizawa Y, Noguchi D, Gyoten K, Hayasaki A, Fujii T, Murata Y, Tanemura A, Kuriyama N, Azumi Y, Kishiwada M, Mizuno S, Usui M, Sakurai H, Isaji S. Kusafuka T, et al. Among authors: sakurai h. BMC Surg. 2020 Jun 11;20(1):129. doi: 10.1186/s12893-020-00785-w. BMC Surg. 2020. PMID: 32527310 Free PMC article.
2,599 results